170 related articles for article (PubMed ID: 21881830)
1. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
[TBL] [Abstract][Full Text] [Related]
2. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.
Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM
Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018
[TBL] [Abstract][Full Text] [Related]
3. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C
Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334
[TBL] [Abstract][Full Text] [Related]
4. Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.
Weaver KD; Grossman SA; Herman JG
Cancer Invest; 2006 Feb; 24(1):35-40. PubMed ID: 16466990
[TBL] [Abstract][Full Text] [Related]
5. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
[TBL] [Abstract][Full Text] [Related]
6. [Low-molecular DNA in blood plasma and spinal fluid of cancer patients].
Vladimirov VG; Sharova LA
Vopr Onkol; 2010; 56(3):317-20. PubMed ID: 20804054
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
8. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
9. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
11. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.
Nakamizo S; Sasayama T; Shinohara M; Irino Y; Nishiumi S; Nishihara M; Tanaka H; Tanaka K; Mizukawa K; Itoh T; Taniguchi M; Hosoda K; Yoshida M; Kohmura E
J Neurooncol; 2013 May; 113(1):65-74. PubMed ID: 23456655
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.
Shnaper S; Desbaillets I; Brown DA; Murat A; Migliavacca E; Schluep M; Ostermann S; Hamou MF; Stupp R; Breit SN; de Tribolet N; Hegi ME
Int J Cancer; 2009 Dec; 125(11):2624-30. PubMed ID: 19521960
[TBL] [Abstract][Full Text] [Related]
14. DNA Associated with Circulating Exosomes as a Biomarker for Glioma.
Vaidya M; Sugaya K
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33137926
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.
Hao TB; Shi W; Shen XJ; Qi J; Wu XH; Wu Y; Tang YY; Ju SQ
Br J Cancer; 2014 Oct; 111(8):1482-9. PubMed ID: 25157833
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C
Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411
[TBL] [Abstract][Full Text] [Related]
17. Circulating glioma biomarkers.
Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
[TBL] [Abstract][Full Text] [Related]
18. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
20. Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid.
Fukushima Y; Tamura M; Nakagawa H; Itoh K
J Neurosurg; 2007 Sep; 107(3):578-85. PubMed ID: 17886558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
